FEMASYS INC

FEMY
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001339005

Price chart

Open-market purchases and sales by FEMY insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 11, 20268:54 PM ETAug 7, 2026Mifek Jeffrey GeraldChief Clinical-Medical AffairsPPurchaseCommon Stock+3.13K$3.20+$10K3.13KNew positionSEC
Aug 11, 20268:44 PM ETAug 7, 2026Sipos Jeremy AlexanderChief Technology OfficerPPurchaseCommon Stock+3.13K$3.20+$10K3.13KNew positionSEC
Aug 11, 20268:40 PM ETAug 7, 2026Canning John CharlesChief Operating OfficerPPurchaseCommon Stock+4.38K$3.20+$14K4.38KNew positionSEC
Aug 11, 20268:37 PM ETAug 7, 2026Elefant DovChief Financial OfficerPPurchaseCommon Stock+15.63K$3.20+$50K15.63KNew positionSEC
Aug 11, 20268:30 PM ETAug 7, 2026Lee-Sepsick KathyChief Executive OfficerPPurchaseCommon Stock+15.63K$3.20+$50K15.63KNew positionSEC

The largest institutional positions in FEMY at the end of Q2 2026.

Institutions holding FEMY in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Dauntless Investment Group, LLC1,867,987$7.81M13.54%−4,165,043−69.0%Reduced
VANGUARD CAPITAL MANAGEMENT LLC62,232$260.13K0.00%−1,174,441−95.0%Reduced
JANE STREET GROUP, LLC52,511$219.5K0.00%+20,235+62.7%Added
GEODE CAPITAL MANAGEMENT, LLC30,920$129.25K0.00%−590,446−95.0%Reduced
UBS Group AG18,777$78.49K0.00%−43,152−69.7%Reduced